Twist Bioscience Corp Total Liabilities
Twist Bioscience Corp total liabilities. Based on the latest financial reports, Twist Bioscience Corp (TWST) has total liabilities worth $226.70 Million USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check TWST cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Twist Bioscience Corp (2016–2025)
Total liabilities of Twist Bioscience Corp from 2016 to 2025. This chart illustrates how Twist Bioscience Corp's total liabilities have evolved over time, based on quarterly financial data. Explore how much of Twist Bioscience Corp's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Twist Bioscience Corp Competitors by Total Liabilities
The table below lists competitors of Twist Bioscience Corp ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Svenska Cellulosa Aktiebolaget SCA (publ)
ST:SCA-B
|
Sweden | Skr44.94 Billion |
|
Sinoma Science & Technology Co Ltd
SHE:002080
|
China | CN¥40.24 Billion |
|
China Eastern Airlines Corp Ltd
SHG:600115
|
China | CN¥260.89 Billion |
|
KT Corporation
NYSE:KT
|
USA | $23.17 Trillion |
|
Kesko Oyj
HE:KESKOB
|
Finland | €6.00 Billion |
|
Anhui Tongguan Copper Foil Group Co. Ltd.
SHE:301217
|
China | CN¥2.30 Billion |
|
SalMar ASA
OL:SALM
|
Norway | Nkr37.37 Billion |
|
Lotus Bakeries
BR:LOTB
|
Belgium | €676.92 Million |
Liability Composition Analysis (2016–2025)
This chart breaks down Twist Bioscience Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Twist Bioscience Corp balance sheet assets.
Liquidity & Leverage Metrics
Twist Bioscience Corp Total Liabilities Ratios Explained
Twist Bioscience Corp total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.67 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.51 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.34 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Twist Bioscience Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Twist Bioscience Corp (2016–2025)
The table below shows the annual total liabilities of Twist Bioscience Corp from 2016 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-09-30 | $168.90 Million | +19.25% |
| 2024-09-30 | $141.63 Million | -7.41% |
| 2023-09-30 | $152.97 Million | -11.06% |
| 2022-09-30 | $171.99 Million | +41.82% |
| 2021-09-30 | $121.28 Million | +93.67% |
| 2020-09-30 | $62.62 Million | +79.37% |
| 2019-09-30 | $34.91 Million | -88.99% |
| 2018-09-30 | $317.21 Million | +44.84% |
| 2017-09-30 | $219.01 Million | +43.08% |
| 2016-09-30 | $153.07 Million | -- |
About Twist Bioscience Corp
Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo … Read more